alendronate and ronacaleret

alendronate has been researched along with ronacaleret in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilezikian, JP; Bone, HG; Cicconetti, G; Dabrowski, CE; Fitzpatrick, LA; Gordon, DN; Papapoulos, S	1

Trials

1 trial(s) available for alendronate and ronacaleret

Article	Year
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:8 Topics: Administration, Oral; Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Female; Humans; Indans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Patient Compliance; Phenylpropionates; Receptors, Calcium-Sensing; Teriparatide	2011

Article

Year

The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.

The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:8

Topics: Administration, Oral; Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcium; Female; Humans; Indans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Patient Compliance; Phenylpropionates; Receptors, Calcium-Sensing; Teriparatide

2011